Evgen Pharma ( (GB:TCF) ) has shared an update.
Theracryf PLC, a UK-based issuer, has reported a change in its major holdings due to an acquisition or disposal of voting rights by First Equity Limited, based in London. The notification indicates that the voting rights held by First Equity Limited have decreased from 7.300860% to 6.113760%, with a total of 130,200,000 voting rights now held in the issuer. This change reflects a shift in the company’s shareholder structure, potentially impacting its governance and strategic decision-making.
More about Evgen Pharma
YTD Price Performance: -56.73%
Average Trading Volume: 1,887,416
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
Learn more about TCF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com